{"id":"W2106545303","doi":"10.1016/j.cell.2010.07.044","title":"Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma","year":2010,"lang":"en","type":"article","venue":"Cell","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":1080,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Heart, Lung, and Blood Institute; Wellcome Trust; Howard Hughes Medical Institute","keywords":"Rituximab; CD47; Lymphoma; Monoclonal antibody; Antibody; Immunology; CD20; Cancer research; Biology; Monoclonal antibody therapy; Blocking antibody; Medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009338248667400371,"score_gpt":0.2858738822716768,"score_spread":0.2765356336042765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}